[1] Lo S, Wei FC. Double free flap reconstruction of through-and-through oromandibulofacial defects [J]. Eur J Plast Surg, 2012, 35(5):335-343. [2] Rana M, Warraich R, Horst Kokemüller, et al. Reconstruction of mandibular defects-clinical retrospective research over a 10-year period [J]. Head Neck Oncol, 2011, 3(1):23. [3] Hakim SG, Jeske G, Jacobsen HC, et al. The eligibility of the free fibula graft for masticatory rehabilitation using monocortical implants insertion-a morphologic and biomechanical study [J]. Clin Oral Investig, 2012, 16(2):673-678. [4] Anne-Gaëlle Bodard, Salino S, Desoutter A, et al. Assessment of functional improvement with implant-supported prosthetic rehabilitation after mandibular reconstruction with a microvascular free fibula flap: A study of 25 patients [J]. J Prosthet Dent, 2015,113(2):140-145. [5] Ruggiero SL, Dodson TB, Aghaloo T, et al. American association of oral and maxillofacial surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update [J]. J Oral Maxillofac Surg, 2022, 80(5):920-943. [6] 潘剑,刘济远.药物相关性颌骨坏死的发病机制及其防治[J].华西口腔医学杂志,2021,39(3):245-254. [7] Kawahara M, Kuroshima S, Sawase T. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review [J]. Int J Implant Dent, 2021, 7(1):47. [8] 孙国文,田美. 药物相关性颌骨坏死不同阶段治疗方法述评[J].口腔颌面外科杂志,2022,32(3):135-142. [9] Pichardo SEC, Ten Broek FW, Richard van Merkesteyn JP. Treatment of pathologic fractures of the mandible in stage Ⅲ medication-related osteonecrosis of the jaw-an observational study[J]. J Craniomaxillofac Surg, 2018, 46(8): 1241-1246. [10] Kuroshima S, Sasaki M, Sawase T. Medication-related osteonecrosis of the jaw: A literature review [J]. J Oral Biosci, 2019,61(2):99-104. |